2076 - 2100 of 7939 Results
Title
Year
-
RESTRICTEDTitle: Special Issue on new therapeutic approaches to Parkinson diseaseJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 208Issue #:Start Page: 108998End Page: 108998Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2022.108998Citation Count: 3
-
OPENTitle: Assessing Gq-GPCR–induced human astrocyte reactivity using bioengineered neural organoidsJournal Name: Journal of Cell BiologyPublisher: Rockefeller University PressVol: 221Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-saDOI - Digital Object Identifier: 10.1083/jcb.202107135Best OA location URL: https://rupress.org/jcb/article-pdf/221/4/e202107135/1428539/jcb_202107135.pdfCitation Count: 12
- Autonomic and Depression Symptoms in Parkinson’s Disease: Clinical Evidence for Overlapping Physiology2022RESTRICTEDTitle: Autonomic and Depression Symptoms in Parkinson’s Disease: Clinical Evidence for Overlapping PhysiologyJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 12Issue #: 3Start Page: 1059End Page: 1067Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.3233/jpd-213075Citation Count: 10
-
OPENTitle: How Prolonged Isolation Affects People With Parkinson Disease During the COVID-19 PandemicJournal Name: JAMAPublisher: American Medical Association (AMA)Vol: 327Issue #: 9Start Page: 801End Page: 801Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/jama.2022.1510Best OA location URL: https://jamanetwork.com/journals/jama/articlepdf/2789055/jama_suran_2022_mn_220006_1645750114.50702.pdfCitation Count: 5
- Immediate-release/extended-release amantadine (OS320) to treat Parkinson's disease with levodopa-induced dyskinesia: Analysis of the randomized, controlled ALLAY-LID studies2022OPENTitle: Immediate-release/extended-release amantadine (OS320) to treat Parkinson's disease with levodopa-induced dyskinesia: Analysis of the randomized, controlled ALLAY-LID studiesJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 96Issue #:Start Page: 65End Page: 73Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.01.022Best OA location URL: http://www.prd-journal.com/article/S135380202200030X/pdfCitation Count: 8
- Multi-transcriptomic analysis points to early organelle dysfunction in human astrocytes in Alzheimer's disease2022OPENTitle: Multi-transcriptomic analysis points to early organelle dysfunction in human astrocytes in Alzheimer's diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 166Issue #:Start Page: 105655End Page: 105655Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2022.105655Best OA location URL: https://doi.org/10.1016/j.nbd.2022.105655Citation Count: 47
-
RESTRICTEDTitle: The Neuroinflammatory Acute Phase Response in Parkinsonian‐Related DisordersJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 5Start Page: 993End Page: 1003Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28958Citation Count: 10
-
RESTRICTEDTitle: The Utility of Breath Analysis in the Diagnosis and Staging of Parkinson’s DiseaseJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 12Issue #: 3Start Page: 993End Page: 1002Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.3233/jpd-213133Citation Count: 7
- Enhancing clinical information display to improve patient encounters: human-centered design and evaluation of the Parkinson’s Disease-BRIDGE platform (Preprint)2022OPENTitle: Enhancing clinical information display to improve patient encounters: human-centered design and evaluation of the Parkinson’s Disease-BRIDGE platform (Preprint)Journal Name: JMIR Human FactorsPublisher: JMIR Publications Inc.Vol: 9Issue #: 2Start Page: e33967End Page: e33967Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.2196/33967Best OA location URL: https://jmir.org/api/download?alt_name=humanfactors_v9i2e33967_app1.pdf&filename=26fb494cb2a4c1c5dad0b68f24b7d1a8.pdfCitation Count: 7
- Implementation Experience with a 30-Day Hospital Readmission Risk Score in a Large, Integrated Health System: A Retrospective Study2022OPENTitle: Implementation Experience with a 30-Day Hospital Readmission Risk Score in a Large, Integrated Health System: A Retrospective StudyJournal Name: Journal of General Internal MedicinePublisher: Springer Science and Business Media LLCVol: 37Issue #: 12Start Page: 3054End Page: 3061Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s11606-021-07277-4Best OA location URL: https://link.springer.com/content/pdf/10.1007/s11606-021-07277-4.pdfCitation Count: 2
- White Matter Microstructural Alterations in Newly Diagnosed Parkinson’s Disease: A Whole-Brain Analysis Using dMRI2022OPENTitle: White Matter Microstructural Alterations in Newly Diagnosed Parkinson’s Disease: A Whole-Brain Analysis Using dMRIJournal Name: Brain SciencesPublisher: MDPI AGVol: 12Issue #: 2Start Page: 227End Page: 227Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/brainsci12020227Best OA location URL: https://www.mdpi.com/2076-3425/12/2/227/pdf?version=1644561488Citation Count: 2
-
RESTRICTEDTitle: Alpha and Beta Synucleins: From Pathophysiology to Clinical Application as BiomarkersJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 4Start Page: 669End Page: 683Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28941Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28941Citation Count: 33
-
OPENTitle: Plasma Metabolite Signature Classifies Male LRRK2 Parkinson’s Disease PatientsJournal Name: MetabolitesPublisher: MDPI AGVol: 12Issue #: 2Start Page: 149End Page: 149Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/metabo12020149Best OA location URL: https://www.mdpi.com/2218-1989/12/2/149/pdf?version=1645608748Citation Count: 12
-
OPENTitle: Automated Video Monitoring of Unmarked and Marked Honey Bees at the Hive EntranceJournal Name: Frontiers in Computer SciencePublisher: Frontiers Media SAVol: 3Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.3389/fcomp.2021.769338Best OA location URL: https://www.frontiersin.org/articles/10.3389/fcomp.2021.769338/pdfCitation Count: 10
-
RESTRICTEDTitle: Blood GFAP as an emerging biomarker in brain and spinal cord disordersJournal Name: Nature Reviews NeurologyPublisher: Springer Science and Business Media LLCVol: 18Issue #: 3Start Page: 158End Page: 172Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/s41582-021-00616-3Best OA location URL: https://www.nature.com/articles/s41582-021-00616-3.pdfCitation Count: 207
- Different α-synuclein prion strains cause dementia with Lewy bodies and multiple system atrophy2022OPENTitle: Different α-synuclein prion strains cause dementia with Lewy bodies and multiple system atrophyJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 119Issue #: 6Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1073/pnas.2113489119Best OA location URL: https://doi.org/10.1073/pnas.2113489119Citation Count: 48
- Invariable Ribosome Stoichiometry During Murine Erythroid Differentiation: Implications for Understanding Ribosomopathies2022OPENTitle: Invariable Ribosome Stoichiometry During Murine Erythroid Differentiation: Implications for Understanding RibosomopathiesJournal Name: Frontiers in Molecular BiosciencesPublisher: Frontiers Media SAVol: 9Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fmolb.2022.805541Best OA location URL: https://www.frontiersin.org/articles/10.3389/fmolb.2022.805541/pdfCitation Count: 3
-
OPENTitle: Mapping dopaminergic projections in the human brain with resting-state fMRIJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 11Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.7554/elife.71846Best OA location URL: https://doi.org/10.7554/elife.71846Citation Count: 21
-
RESTRICTEDTitle: Neuroimaging Pearls from the MDS Congress Video Challenge. Part 1: Genetic DisordersJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 9Issue #: 3Start Page: 297End Page: 310Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13412Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13412Citation Count: 2
-
RESTRICTEDTitle: Neuroimaging Pearls from the MDS Congress Video Challenge. Part 2: Acquired DisordersJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 9Issue #: 3Start Page: 311End Page: 325Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13415Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13415Citation Count: 2
- An open-label prospective pilot trial of nucleus accumbens deep brain stimulation for children with autism spectrum disorder and severe, refractory self-injurious behavior: study protocol2022OPENTitle: An open-label prospective pilot trial of nucleus accumbens deep brain stimulation for children with autism spectrum disorder and severe, refractory self-injurious behavior: study protocolJournal Name: Pilot and Feasibility StudiesPublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40814-022-00988-3Best OA location URL: https://pilotfeasibilitystudies.biomedcentral.com/track/pdf/10.1186/s40814-022-00988-3Citation Count: 5
- Durability of the Clinical Benefit of Droxidopa for Neurogenic Orthostatic Hypotension During 12 Weeks of Open-Label Treatment2022OPENTitle: Durability of the Clinical Benefit of Droxidopa for Neurogenic Orthostatic Hypotension During 12 Weeks of Open-Label TreatmentJournal Name: Neurology and TherapyPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page: 459End Page: 469Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s40120-021-00317-5Best OA location URL: https://link.springer.com/content/pdf/10.1007/s40120-021-00317-5.pdfCitation Count: 5
-
OPENTitle: GBA and APOE Impact Cognitive Decline in Parkinson's Disease: A 10‐Year Population‐Based StudyJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 5Start Page: 1016End Page: 1027Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1002/mds.28932Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28932Citation Count: 61
- Transition and Sustainability of an Online Care Model for People With Parkinson's Disease in Response to the COVID-19 Pandemic2022OPENTitle: Transition and Sustainability of an Online Care Model for People With Parkinson's Disease in Response to the COVID-19 PandemicJournal Name: Frontiers in Public HealthPublisher: Frontiers Media SAVol: 9Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fpubh.2021.772805Best OA location URL: https://www.frontiersin.org/articles/10.3389/fpubh.2021.772805/pdfCitation Count: 7
-
RESTRICTEDTitle: Association of Essential Tremor With Novel Risk LociJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 79Issue #: 2Start Page: 185End Page: 185Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1001/jamaneurol.2021.4781Best OA location URL: https://jamanetwork.com/journals/jamaneurology/articlepdf/2787239/jamaneurology_liao_2022_oi_210083_1644604359.06757.pdfCitation Count: 21